Elanco Animal Health Incorporated
TypePublic
IndustryPharmaceutical (animal)
Founded1954 Edit this on Wikidata
HeadquartersGreenfield, Indiana, U.S.
Key people
  • R. David Hoover (Chairman)
  • Jeff Simmons (CEO)
ProductsPharmaceutical drugs (animal)
RevenueIncrease US$4.765 billion (2021)[1]
Increase –US$0.567 billion (2021)[1]
Increase –US$0.472 billion (2021)[1]
Total assetsDecrease US$16.483 billion (2021)[1]
Total equityDecrease US$7.538 billion (2021)[1]
Number of employees
10,200 (2021)[2]
Websiteelanco.com

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.[3]

History

The company traces its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage with the new plant and animal sciences research being combined into Lilly's Agro-Industrial division led by George Barnes. In the 1960s, the Agro-Industrial division was reorganised launching Elanco Products, short for the parent company name, Eli Lilly and Company.[4]

In the 1980s research moved away from plant sciences and focused on animal health and food quality. In the 1990s another reorganisation led to the company being renamed Elanco Animal Health, focusing solely on animal health.[4]

In 2007 the business acquired Ivy Animal Health and launched its companion animal business. In 2008 Elanco partnered with Heifer International. In 2009 the business launched its data analytics business, Elanco Knowledge Solutions.[4]

In 2010 the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site.[5] In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health.[6] In 2012 the business acquired ChemGen Corp.[7] In 2014, the business acquired Lohmann SE and Lohmann Animal Health for an undisclosed sum[8] and Novartis Animal Health for $5.4 billion. In 2016 Elanco expanded its US-based business, acquiring vaccines from Boehringer Ingelheim Vetmedica for $885 million.[9]

In 2013, Elanco made a $100M investment in China Animal Healthcare.[10]

In 2018, Lilly announced plans to separate its Elanco Animal Health unit from the rest of the business via an initial public offering on the New York Stock Exchange, with the stock-ticker ELAN. In 2019, the divestiture was completed and Elanco launched on the New York Stock Exchange. In the same year, the US FDA approved rabacfosadine, a first-in-class treatment for canine lymphoma. The business continued to expand is US-business, acquiring Aratana Therapeutics,[11] and its first-in-class treatment for canine osteoarthritis. Elanco also announced it would acquire the developer of vaccines for bacterial disease prevention in food-animals, Prevtec Microbia, Inc.[12] In the same year the business announced it would acquire Bayer's animal health business for $7.6 billion.[13][14]

On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021.[15]

In August 2021, Elanco announced it had closed its acquisition of Kindred Biosciences.[16]

Elanco's flea and tick collar, branded "Seresto," which was developed by Bayer Animal Health and acquired by Elanco in 2020, has been linked to more than 98,000 incidents of poisoning by pesticide, including more than 2,000 pet deaths, according to a 2022 report by a subcommittee of the House Committee on Oversight and Reform. The collars are not registered for sale in Canada.[17][18]

On July 13, 2023, following a multi-year review, the EPA announced that they were unable to determine whether Seresto was the cause for reported animal deaths. The EPA limited the collar's registration to five years instead of the normal fifteen years registration, as other pesticides normally receive. Elanco and the EPA also agreed to develop a program designed to enhance data collection for adverse event reports and continued annual enhanced reporting of Seresto adverse event data.[19]

Acquisitions

Elanco Acquisitions

References

  1. 1 2 3 4 5 "2021 Annual Report" (PDF). Elanco. 31 December 2021. Retrieved 17 March 2023.
  2. ↑ "Elanco Animal Health Company Profile".
  3. ↑ "Elanco Moving Global HQ to Indy".
  4. 1 2 3 "About Elanco | Solutions for Protecting and Enhancing Animal Health". www.elanco.com.
  5. ↑ "Lilly to Acquire European Rights to Pfizer Animal Health Assets". www.elanco.com.
  6. ↑ "Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health". www.elanco.com.
  7. ↑ "Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp". www.elanco.com. 24 January 2012. Archived from the original on 17 July 2020. Retrieved 17 July 2020.
  8. ↑ "Elanco Announces Agreement to Acquire Lohmann Animal Health". www.elanco.com.
  9. ↑ "Lilly Finalizes Novartis Animal Health Acquisition". www.elanco.com.
  10. ↑ "Elanco invests in China Animal Healthcare". www.feedstuffs.com. 12 April 2013.
  11. ↑ "Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus". www.elanco.com.
  12. ↑ "Elanco Announces Acquisition of Prevtec Microbia Swine Vaccine Company". www.elanco.com.
  13. ↑ "Elanco to divest brands, forgo Canadian rights for Bayer's unit deal". Reuters. 14 July 2020 – via uk.reuters.com.
  14. ↑ "Elanco Animal Health wins approval to buy Bayer unit". Reuters. 15 July 2020 – via uk.reuters.com.
  15. ↑ Burris, Alexandria. "Former GM stamping plant will be home to Elanco Animal Health headquarters". The Indianapolis Star. Retrieved 5 December 2020.
  16. ↑ "Elanco Closes Acquisition of Kindred Biosciences".
  17. ↑ "Lawmakers say this flea collar should be recalled after 2,500 pet deaths". FOX13 News. 16 June 2022. Retrieved 16 June 2022.
  18. ↑ Novak, Matt (16 June 2022). "Seresto Flea Collars Might Be Banned After Lawmakers Grill CEO". Gizmodo. Retrieved 16 June 2022.
  19. ↑ Hettinger, Johnathan (14 July 2023). "EPA rules popular Seresto flea collar stays on the market, adds more reporting requirements". USA Today. Retrieved 8 August 2023.
  20. ↑ "Eli Lilly and Company Announces Acquisition of Ivy Animal Health". PRNewswire. 25 May 2007.
  21. ↑ "Lilly to Acquire European Rights to Pfizer Animal Health Assets". PRNewswire. 8 March 2010.
  22. ↑ "Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health". PRNewswire. 14 March 2011.
  23. ↑ "Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp". PRNewswire. 24 January 2012.
  24. ↑ "Elanco Announces Agreement to Acquire Lohmann Animal Health". PRNewswire. 24 February 2014.
  • Official website
  • Business data for Elanco Animal Health Incorporated:
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.